KRMD vs. ESTA, AXGN, CBLL, IRMD, AVNS, SIBN, TMCI, KIDS, DCTH, and CLPT
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include Establishment Labs (ESTA), AxoGen (AXGN), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), Treace Medical Concepts (TMCI), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.
KORU Medical Systems vs.
KORU Medical Systems (NASDAQ:KRMD) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk, community ranking and dividends.
KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.
Establishment Labs received 73 more outperform votes than KORU Medical Systems when rated by MarketBeat users. However, 63.77% of users gave KORU Medical Systems an outperform vote while only 61.90% of users gave Establishment Labs an outperform vote.
KORU Medical Systems has a net margin of -37.42% compared to Establishment Labs' net margin of -46.13%. KORU Medical Systems' return on equity of -24.60% beat Establishment Labs' return on equity.
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 25.6% of KORU Medical Systems shares are held by insiders. Comparatively, 11.4% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Establishment Labs had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 5 mentions for Establishment Labs and 4 mentions for KORU Medical Systems. Establishment Labs' average media sentiment score of 0.25 beat KORU Medical Systems' score of -0.15 indicating that Establishment Labs is being referred to more favorably in the news media.
KORU Medical Systems currently has a consensus target price of $4.70, indicating a potential upside of 26.68%. Establishment Labs has a consensus target price of $60.60, indicating a potential upside of 81.37%. Given Establishment Labs' higher possible upside, analysts clearly believe Establishment Labs is more favorable than KORU Medical Systems.
KORU Medical Systems has higher earnings, but lower revenue than Establishment Labs. KORU Medical Systems is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.
Summary
Establishment Labs beats KORU Medical Systems on 9 of the 16 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
This page (NASDAQ:KRMD) was last updated on 2/22/2025 by MarketBeat.com Staff
